Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection

Kaminskiy, G. D.; Pronin, A. J.
January 2010
Journal of the International AIDS Society;2010 Supplement 4, Vol. 13 Issue Suppl 4, p1
Academic Journal
An abstract of the article "Immune impairment and adaptive response in relation to antiretroviral therapy of HIV-infection," by G. D. Kaminskiy and colleagues is presented.


Related Articles

  • HAART may be effective for HIV epidemic control.  // PharmacoEconomics & Outcomes News;7/24/2010, Issue 608, p4 

    The article discusses research study on the association of highly active antiretroviral therapy, coverage, population viral load and yearly new human immunodeficiency virus (HIV) diagnoses in British Columbia, referencing a study by J. S. G. Montaner and colleagues published in the July 18, 2010...

  • Abacavir/efavirenz/nelfinavir.  // Reactions Weekly;2/13/2010, Issue 1288, p5 

    The article describes the case of a 51-year-old man who developed partial anterior interosseous nerve palsy during highly active antiretroviral therapy (HAART) with abacavir, efavirenz and nelfinavir for a HIV infection.

  • Taking care of the caretakers to enhance antiretroviral adherence in HIV-infected children and adolescents. Bryson, Yvonne // Jornal de Pediatria;Nov/Dec2014, Vol. 90 Issue 6, p533 

    No abstract available.

  • Editorial Commentary: China, HIV, and Syphilis Among Men Who Have Sex With Men: An Urgent Call to Action. Muessig, Kathryn E.; Cohen, Myron S. // Clinical Infectious Diseases;Jul2013, Vol. 57 Issue 2, p310 

    An introduction is presented in which the editor discusses various topics within the issue including prevalence of HIV and syphilis among sex workers and men who have sex with men (MSM) in China and antiretroviral therapy (ART).

  • HIV/HAART and the brain - what's going on? Portegies, P. // Journal of the International AIDS Society;2010 Supplement 4, Vol. 13 Issue Suppl 4, p1 

    An abstract of the research paper "HIV/HAART and the Brain: What's Going on? ," by P. Portegies which was presented at the Tenth International Congress on Drug Therapy in HIV Infection held at Glasgow, Scotland from November 7-11, 2010 is presented.

  • Annals of Internal Medicine: HIV treatment use increases in the US.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article informs that the usage of highly active antiretroviral therapy for the treatment of Human Immunodeficiency Virus (HIV)-infection has increased in the U.S.

  • Cases falling, treatment lagging. Kondro, Wayne // CMAJ: Canadian Medical Association Journal;1/8/2013, Vol. 185 Issue 1, pE40 

    The article informs that 2.5 million people are reported to be infected by HIV infections till the year 2011 and just 1.4 million people have received antiretroviral therapy in Canada.

  • Antiretroviral therapy may be recommended from diagnosis of HIV. O'Dowd, Adrian // BMJ: British Medical Journal;6/6/2015, Vol. 350 Issue 8011, ph2963 

    The article discusses results from the Strategic Timing of Antiretroviral Treatment 2015 study that recommends antiretroviral treatment for people diagnosed with HIV due to lower risks of developing AIDS or other serious illnesses.

  • A Woman With AIDS and a Neglected Disease Presenting With Coma, Periumbilical Purpuric Rash, and Alveolar Hemorrhage.  // Clinical Infectious Diseases;11/1/2016, Vol. 63 Issue 9, p1212 

    The article presents a case study of a 40-year-old woman who had human immunodeficiency virus (HIV) infection and was underwent to highly active antiretroviral therapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics